Tuesday, August 05, 2025 | 11:26 AM ISTहिंदी में पढें
Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
Aarey Drugs & Pharmaceuticals Ltd
Board Meeting Outcome for Intimation Regarding Appointment Of Company Secretary And Compliance Officer Of The Company Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
04:40 PM, 6th Mar 2025
Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations 2015 read with Para A Part A of Schedule Ill of said Regulations we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Thursday March 6 2025 based on the recommendation of Nomination and Remuneration Committee approved the appointment of CS Kailash Chand Jethlia(Membership No.: F1476) as Company Secretary and Compliance Officer w.e.f. March 6 2025
